openPR Logo
Press release

Peptide-Drug Conjugates (PDCs) Market Report- Expansive Coverage on the Profit Sources

12-15-2023 05:56 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: Insightace analytic

Peptide-Drug Conjugates (PDCs) Market Report- Expansive

InsightAce Analytic Pvt. Ltd. announces the release of market assessment report on "Global Peptide-drug Conjugates (PDCs) Market By Product (Lutetium Lu 177 dotatate, Melflufen, ANG1005, BT1718, CBX-12, and Other Pipeline Products) By Indication (Relapsed/Refractory Multiple Myeloma, Neuroendocrine Tumors (NETs), Gastric Cancers, Acromegaly, Ophthalmology, and Other Cancer Indications. )- Technology Trends, Industry Competition Analysis, Revenue and Forecast Till 2031".

The Peptide-Drug Conjugates (PDCs) Market Size is valued at 696.2 Million in 2022 and is predicted to reach 3113.7 Million by the year 2031 at a 18.2 % CAGR during the forecast period for 2023-2031.

Request for Free Sample Pages: https://www.insightaceanalytic.com/request-sample/1351

peptidedrug-conjugates-pdcs-market/1351
The peptide drug conjugates are targeted therapeutic drugs, targeting the tumor cell to release the cytotoxin. The swelling investments by key players to develop promising therapies are anticipated to fuel the market growth over the forecast period. The emergence of Peptide-Drug Conjugates (PDCs) therapy for patients suffering from different types of cancers is believed to create a number of clinical opportunities during the forecast period. PDC uses a peptide chain of about ten amino acids to target tumour cells, and its molecular weight is smaller than ADC, which can be rapidly enriched to tumour sites. At the same time, drug molecules in blood can be cleared quickly with a short half-life, helping to reduce toxic side effects caused by off-targeting.

Peptide-drug conjugates (PDCs) are a novel targeted therapy that exhibits enhanced tumour penetrance and selectivity. Peptide-drug conjugates (PDCs) are a promising field of study, as evidenced by the two PDCs now available on the market. In addition, PDCs with the proper design and focus is expected to affect the targeted therapeutic market by delivering safer medications. The increasing number of pharmaceutical drug innovations is expected to fuel the growth of peptide-drug conjugates (PDCs) market in the near future. Also, in the coming days, there will be rapid approval of peptide drug conjugates in treating cancers due to the robust clinical pipeline of drugs. Despite these, the peptide drug conjugates have several limitations which hinder the growth of the PDCs market. Major driving factors of peptide-drug conjugates (PDCs) market are the increasing need for therapeutic drugs, high prevalence of cancer diseases, rising number of clinical trials, and increasing investments by key players to develop promising therapies. Furthermore, advanced medical technologies, growth in the population, and a growing number of health-conscious people enhance the market growth.

However, the high-cost treatments, complex procedures, and lack of strict government laws limit the market growth. Moreover, the COVID-19 pandemic has negatively impacted this market due to the lockdown situation. In addition, the pipeline product approval process may hamper the product market and production as a lot of clinical trials are going on today. On the other hand, FDA has approved very few pipeline products regarding peptide drug conjugates in the last five years, which will impact the market in the forecasting period.

Enquiry Before Buying: https://www.insightaceanalytic.com/enquiry-before-buying/1351

At the regional level, North America, followed by the Europe region, is expected to hold the highest share of this market over the forecast period due to the high prevalence of cancer, fast adoption of advanced technologies, rising awareness about therapeutic drugs, and increasing government investments and funding in R&D of therapeutic medications. In addition, the Asia-Pacific region is expected to show significant market growth in the future owing to the advancement of modern technologies and the rising prevalence of cancer.

The key players involved in peptide-drug conjugates (PDCs) industry are Novartis AG, AstraZeneca, Bicycle Therapeutics, Cybrexa Therapeutics, Esperance Pharmaceuticals, Oncopeptides AB, Pepgen Corporation, Soricimed Biopharma, Theratechnologies, Pfizer Inc, Validus Pharmaceuticals LLC, Antisense Therapeutics, Midatech Pharma PLC, Ipsen Pharma, Chiasma, Inc., Peptron, Inc., CRINETICS PHARMACEUTICALS, Dauntless Pharmaceuticals, Camurus AB, Teva Pharmaceuticals Inc., Pharmaspur, Aspire Pharmaceuticals, Ionis Pharmaceuticals Inc, Midatech Pharma Plc, and Other Prominent Players. This field's leading players use strategies like novel therapy innovations, partnerships, collaborations, mergers, and agreements.

Key developments in the market
• In Dec 2021, A strategic partnership agreement was signed between Coherent Biopharma and WuXi STA. In order to speed up the development of its current and future drug candidates (small molecules, peptides, oligonucleotides, complex chemical conjugates, etc.), from API to drug product, the company will offer Coherent Biopharma integrated CMC services.
• In Oct 2021, Oncopeptides AB announced the withdrawal of Pepaxto® (INN melphalan flufenamide) from the US market. Oncopeptides will collaborate with the FDA to keep the drug available for patients who are currently receiving Pepaxto treatment.
• In July 2020, AstraZeneca and Daiichi Sankyo formed a new $6 billion global ADC alliance to co-develop and commercialise DS-1062, a TROP2 directed DXd antibody-drug conjugate in Phase I for non-small cell lung cancer and breast cancer. The businesses will share development and commercialization costs as well as profits from DS-1062 worldwide, except for Japan.
• In June 2019, Novartis AG and PeptiDream Inc. signed a new Peptide Drug Conjugate "PDC" collaboration agreement to initiate macrocyclic peptide discovery, which will be used to address therapeutic and diagnostic applications.

Get Specific Chapter/Information From The Report: https://www.insightaceanalytic.com/customisation/1351

Market Segments
Global peptide-drug Conjugates (PDCs) Market, by Product, 2022-2030 (Value US$ Mn)
• Lutetium Lu 177 dotatate
• Melflufen
• ANG1005
• BT1718
• CBX-12
• Other Pipeline Products

Global peptide-drug Conjugates (PDCs) Market, by Indication, 2022-2030 (Value US$ Mn)
• Relapsed/Refractory Multiple Myeloma
• Neuroendocrine Tumors (NETs)
• Gastric Cancers
• Acromegaly
• Ophthalmology
• Other Cancer Indication

Global peptide-drug Conjugates (PDCs) Market, by Region, 2022-2030 (Value US$ Mn)
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa
North America Peptide-drug Conjugates (PDCs) Market, by Country, 2022-2030 (Value US$ Mn)
• U.S.
• Canada
Europe Peptide-drug Conjugates (PDCs) Market, by Country, 2022-2030 (Value US$ Mn)
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe
Asia Pacific Peptide-drug Conjugates (PDCs) Market, by Country, 2022-2030 (Value US$ Mn)
• India
• China
• Japan
• South Korea
• Australia & New Zealand
Latin America Peptide-drug Conjugates (PDCs) Market, by Country, 2022-2030 (Value US$ Mn)
• Brazil
• Mexico
• Rest of Latin America
Middle East & Africa Peptide-drug Conjugates (PDCs) Market, by Country, 2022-2030 (Value US$ Mn)
• GCC Countries
• South Africa
• Rest of Middle East & Africa

Why should buy this report:
> To receive a comprehensive analysis of the prospects for global peptide-drug conjugates (PDCs) products
> To receive industry overview and future clinical trial/pipeline trends of global peptide-drug conjugates (PDCs) market
> To analyse the peptide-drug conjugates (PDCs) market drivers and challenges
> To get information on peptide-drug conjugates (PDCs) market size value (US$ Mn) forecast till 2030
> To get information on major Investments, Mergers & Acquisition in global peptide-drug conjugates (PDCs) market industry

For More Information: https://www.insightaceanalytic.com/report/global-peptidedrug-conjugates-pdcs-market/1351

Other Related Reports Published by InsightAce Analytic:
Global Polymer Drug Conjugates Market
Global Neoantigen Peptides Manufacturing Market
Global Antibody Drug Conjugates (Adcs) - Linker And Conjugation Technologies Market
Global Peptide CDMO (Pharmaceutical) Market

Sales Office (U.S.) :
344 Grove St Unit #967 Jersey City, NJ 07302
info@insightaceanalytic.com
North America:
+1 551 226 6109
Asia:
+91 79 72967118

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
Contact Us:
InsightAce Analytic Pvt. Ltd.
Tel.: +1 551 226 6109
Email: info@insightaceanalytic.com
Site Visit: www.insightaceanalytic.com
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Peptide-Drug Conjugates (PDCs) Market Report- Expansive Coverage on the Profit Sources here

News-ID: 3329517 • Views:

More Releases from Insightace analytic

Digital Pathology Market Report- Expansive Coverage on the Profit Sources
Digital Pathology Market Report- Expansive Coverage on the Profit Sources
InsightAce Analytic announces the release of a market assessment report on the "Global Digital Pathology Market Size, Share & Trends Analysis Report By Product (Artificial Intelligence, Scanner, Software, Storage), Type (Human, Veterinary), Application (Teleconsultation, Training, Disease Diagnosis, Drug Discovery), End User (Pharma, Academia, Hospitals)- Market Outlook And Industry Analysis 2031" The global digital pathology market is estimated to reach over USD 2731.95 million by 2031, exhibiting a CAGR of 12.91%
Digital Health Market Future Trends and Scope Analysis Report
Digital Health Market Future Trends and Scope Analysis Report
Digital Health Market Size, Share & Trends Analysis Report By Technology (Tele-healthcare, mHealth, Healthcare Analytics, Digital Health Systems), By Component (Software, Hardware, Services), By Region, And Segment Forecasts, 2024-2031 "Digital Health Market" in terms of revenue was estimated to be worth $248.58 billion in 2023 and is poised to reach $1,004.03 billion by 2031, growing at a CAGR of 19.56% from 2023 to 2031, according to a new report by
Digital Diabetes Management Market Report on the Untapped Growth Opportunities in the Industry
Digital Diabetes Management Market Report on the Untapped Growth Opportunities i …
InsightAce Analytic announces the release of a market assessment report on the "Global Digital Diabetes Management Market - (By Devices (Smart Glucose Meters, Continuous Glucose Monitoring Systems, And Smart Insulin Pens, Smart Insulin Pumps/ Closed-Loop Pumps & Smart Insulin Patches), Application (Diabetes & Blood Glucose Tracking Apps, Obesity & Diet Management Apps), Data Management Software & Platforms And Services), By Device Type (Handheld And Wearable Devices), By End-User(Self/Home Healthcare, Hospitals
Data Center Liquid Cooling Market Exclusive Trends Analysis with Forecast to 2031
Data Center Liquid Cooling Market Exclusive Trends Analysis with Forecast to 203 …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Data Center Liquid Cooling Market Size, Share & Trends Analysis Report By End-User Industry (Financial Services And Insurance (BFSI), Banking, IT And Telecom, Government And Public Sector, Manufacturing, Healthcare, Retail), Data Center (Hyperscale, Colocation, Enterprise) And Solution (Indirect & Direct Cooling)- Market Outlook And Industry Analysis 2031" The Global Data Center Liquid Cooling Market is estimated

All 5 Releases


More Releases for PDC

PDC Drill Bits Market Forecast 2025-2034 | Growth & Trends
The new report by Expert Market Research (EMR), titled 'Global PDC Drill Bits Market Report and Forecast 2025-2034', offers a comprehensive analysis of the global PDC drill bits market. The report evaluates the market based on segments such as type, cutter size, number of blades, application, and major regions including North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. It also studies the latest market trends
PDC Drill Bits Market May Set New Growth Story
Global PDC Drill Bits Market Report from DiMarket highlights deep analysis on market characteristics, sizing, estimates and growth by segmentation, regional breakdowns & country along with competitive landscape, player's market shares, and strategies that are key in the market. The exploration provides a 360° view and insights, highlighting major outcomes of the industry. These insights help the business decision-makers to formulate better business plans and make informed decisions to improved
PDC Drill Bits Market Projections and Strategic Insights 2024-2030
𝐏𝐃𝐂 𝐃𝐫𝐢𝐥𝐥 𝐁𝐢𝐭𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐆𝐫𝐨𝐰𝐭𝐡 𝐨𝐫 𝐃𝐞𝐦𝐚𝐧𝐝 𝐈𝐧𝐜𝐫𝐞𝐚𝐬𝐞 𝐨𝐫 𝐃𝐞𝐜𝐫𝐞𝐚𝐬𝐞 𝐟𝐨𝐫 𝐰𝐡𝐚𝐭 𝐜𝐨𝐧𝐭𝐚𝐢𝐧𝐬 : Synthetic diamond cutters are used in the production of polycrystalline diamond compact (PDC) drill bits. The drilling business was revolutionised by the widespread use of PDC drill bits due to their high penetration rate and wide range of applications. PDC bit utilisation necessitates the use of special PDC cutter technology in order to maximise drilling performance across
PDC Market Sluggish Growth Rate Foreseen by 2023-2029
PDC Market Value growing at a CAGR of 6.75% during 2023-2029. Our report on the Polycrystalline Diamond Compact (PDC) market is an invaluable asset for professionals looking to make informed decisions about the future of the industry. Important changes in the business allow key players to attain larger profits. This PDCMarket study report is the best way to make changes with the help of entire market condition and metrics provided here.
Global PDC Drill Bits Market Research Report 2023-2029
Polycrystalline diamond compact (PDC) drill bits are primarily used in the drilling tools for the oil and gas industry. The fixed-head bits used in the PDC cutters for drilling are called PDC drill bits. PDC Drill Bits report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global PDC Drill Bits market is projected to reach US$ 3758 million in 2029, increasing from US$ 2940.2
Global PDC Drill Bits Market Analysis by 2020-2025
Scope of the Report: The global PDC Drill Bits market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx%% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. Market segmentation PDC Drill Bits market is split by Type and by Application. For the period 2015-2025, the growth